269 related articles for article (PubMed ID: 27358461)
1. Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage.
Kim T; Mehta SL; Kaimal B; Lyons K; Dempsey RJ; Vemuganti R
J Neurosci; 2016 Jun; 36(26):7055-65. PubMed ID: 27358461
[TBL] [Abstract][Full Text] [Related]
2. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
[TBL] [Abstract][Full Text] [Related]
3. Impact of Age and Sex on α-Syn (α-Synuclein) Knockdown-Mediated Poststroke Recovery.
Chelluboina B; Kim T; Mehta SL; Kim JY; Bathula S; Vemuganti R
Stroke; 2020 Oct; 51(10):3138-3141. PubMed ID: 32819195
[TBL] [Abstract][Full Text] [Related]
4. Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
Buck K; Landeck N; Ulusoy A; Majbour NK; El-Agnaf OM; Kirik D
Neurobiol Dis; 2015 Jun; 78():100-14. PubMed ID: 25818009
[TBL] [Abstract][Full Text] [Related]
5. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
6. Neuronal Bmi-1 is critical for melatonin induced ubiquitination and proteasomal degradation of α-synuclein in experimental Parkinson's disease models.
Srivastava AK; Choudhury SR; Karmakar S
Neuropharmacology; 2021 Aug; 194():108372. PubMed ID: 33157086
[TBL] [Abstract][Full Text] [Related]
7. The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein.
Kim T; Mehta SL; Morris-Blanco KC; Chokkalla AK; Chelluboina B; Lopez M; Sullivan R; Kim HT; Cook TD; Kim JY; Kim H; Kim C; Vemuganti R
Sci Signal; 2018 Dec; 11(560):. PubMed ID: 30538177
[TBL] [Abstract][Full Text] [Related]
8. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
[TBL] [Abstract][Full Text] [Related]
9. Deletion of ubiquitin ligase Nedd4l exacerbates ischemic brain damage.
Kim T; Chokkalla AK; Vemuganti R
J Cereb Blood Flow Metab; 2021 May; 41(5):1058-1066. PubMed ID: 32703111
[TBL] [Abstract][Full Text] [Related]
10. S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
Wu W; Sung CC; Yu P; Li J; Chung KKK
PLoS One; 2020; 15(4):e0232019. PubMed ID: 32343709
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA miR-7 Is Essential for Post-stroke Functional Recovery.
Mehta SL; Chokkalla AK; Bathula S; Vemuganti R
Transl Stroke Res; 2023 Feb; 14(1):111-115. PubMed ID: 35088373
[TBL] [Abstract][Full Text] [Related]
12. Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.
Elfarrash S; Jensen NM; Ferreira N; Schmidt SI; Gregersen E; Vestergaard MV; Nabavi S; Meyer M; Jensen PH
PLoS One; 2021; 16(10):e0252635. PubMed ID: 34613964
[TBL] [Abstract][Full Text] [Related]
13. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
14. Pα-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria.
Grassi D; Diaz-Perez N; Volpicelli-Daley LA; Lasmézas CI
Neurobiol Dis; 2019 Apr; 124():248-262. PubMed ID: 30472299
[TBL] [Abstract][Full Text] [Related]
15. Tau and GSK-3β are Critical Contributors to α-Synuclein-Mediated Post-Stroke Brain Damage.
Mehta SL; Kim T; Chelluboina B; Vemuganti R
Neuromolecular Med; 2023 Mar; 25(1):94-101. PubMed ID: 36447045
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein phosphorylation as a therapeutic target in Parkinson's disease.
Braithwaite SP; Stock JB; Mouradian MM
Rev Neurosci; 2012 Mar; 23(2):191-8. PubMed ID: 22499677
[TBL] [Abstract][Full Text] [Related]
17. Exosome release and neuropathology induced by α-synuclein: new insights into protective mechanisms of Drp1 inhibition.
Fan RZ; Guo M; Luo S; Cui M; Tieu K
Acta Neuropathol Commun; 2019 Nov; 7(1):184. PubMed ID: 31744532
[TBL] [Abstract][Full Text] [Related]
18. SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening.
Henderson-Smith A; Chow D; Meechoovet B; Aziz M; Jacobson SA; Shill HA; Sabbagh MN; Caviness JN; Adler CH; Driver-Dunckley ED; Beach TG; Yin H; Dunckley T
PLoS One; 2013; 8(10):e77711. PubMed ID: 24204929
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D.
Takahashi M; Ko LW; Kulathingal J; Jiang P; Sevlever D; Yen SH
Eur J Neurosci; 2007 Aug; 26(4):863-74. PubMed ID: 17714183
[TBL] [Abstract][Full Text] [Related]
20. Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils.
Roux A; Wang X; Becker K; Ma J
J Parkinsons Dis; 2020; 10(4):1397-1410. PubMed ID: 32716318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
